Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-02-06

Clinical Trial Update: Effect of Glutamine on Intestinal Permeability in Crohn's Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing the effect of glutamine on intestinal permeability in Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glutamine (glutamine)

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: Crohn's Disease | Phase 1 | Status: COMPLETED